E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Articles
- Page Path
- HOME > J Liver Cancer > Volume 15(2); 2015 > Article
- Review Article Radiofrequency Ablation for Hepatocellular Carcinoma
- Se Young Jang, So Young Park
-
Journal of Liver Cancer 2015;15(2):79-83
DOI: https://doi.org/10.17998/jlc.15.2.79
Published online: September 30, 2015
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook
-
Corresponding author:
So Young Park,
Email: psyoung0419@gmail.com
- 1,041 Views
- 18 Download
- 0 Crossref
- 0 Scopus
Abstract
Radiofrequency ablation (RFA) takes an important role in management of hepatocellular carcinoma (HCC) as the most popular local therapy in the world. There are many data supporting that RFA is an excellent treatment modality for early-stage HCC with favorable treatment outcomes and minimal invasiveness. Currently, RFA extends treatement indications from unresectable early-stage HCC to intermediate-stage HCC in selected cases. Thus, with technical advances in guidance and ablation as well as devices, RFA widens its territory in the combat field against HCC. (J Liver Cancer 2015;15:79-83)
- Related articles
-
- Radiofrequency for hepatocellular carcinoma larger than 3 cm: potential for applications in daily practice
- Complications of immunotherapy in advanced hepatocellular carcinoma
- A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma
- Imaging prognostication and tumor biology in hepatocellular carcinoma
- The efficacy of treatment for hepatocellular carcinoma in elderly patients
Follow JLC on Twitter